Key finding | Literature review | Interviews | Focus groups | Delphi survey |
---|---|---|---|---|
Limited knowledge of available databases. | Agreement | Agreement | Agreement | Agreement |
Understanding of pharmacovigilance based on WHO definition. | Not addressed | Partial agreement | Partial agreement | Not addressed |
Limitations of current pharmacovigilance systems. | Not addressed | Agreement | Agreement | Not addressed |
Data linkage is useful for pharmacovigilance research. | Agreement | Agreement | Partial agreement | Partial agreement |
Adherence to legislation is necessary. | Agreement | Agreement | Agreement | Not addressed |
It is not clear which legislation is relevant. | Partial agreement | Agreement | Agreement | Not addressed |
Data quality is important for data linkage. | Agreement | Agreement | Agreement | Partial agreement |
The responsibility for the linked data lies with the data owner. | Silence | Agreement | Partial agreement | Silence |
Data ownership needs to be clarified. | Partial agreement | Agreement | Silence | Agreement |
The NHS should be a facilitator of the data linkage. | Silence | Partial agreement | Agreement | Disagreement |
The benefits of the data linkage outweigh the risks. | Partial agreement | Agreement | Partial agreement | Disagreement* |
Professional guidelines might prevent data sharing. | Silence | Agreement | Partial agreement | Disagreement |
Conditional support if data linkage available. | Agreement | Agreement | Agreement | Agreement |
Information governance is a facilitator of data linkage. | Agreement | Agreement | Agreement | Agreement |
Feedback from studies using the linked data is a facilitator. | Agreement | Silence | Agreement | Agreement |
Anonymisation is mandatory. | Partial agreement | Partial agreement | Agreement | Agreement |
Information of and input from the public is important. | Agreement | Agreement | Agreement | Agreement |
An opt-out option for patients is acceptable. | Agreement | Partial agreement | Partial agreement | Agreement |
Technical problems can be solved. | Agreement | Agreement | Agreement | Agreement |
Use of CHI number is acceptable. | Silence | Agreement | Agreement | Agreement |
Safeguards like sanctions should be used. | Agreement | Agreement | Partial agreement | Silence |
Ethical approval will be required. | Agreement | Agreement | Agreement | Agreement |
Data linkage should not impact negatively on current workload. | Agreement | Agreement | Agreement | Agreement |
A certain amount of patient identifiable data will be necessary for the linkage. | Agreement | Agreement | Agreement | Silence |
Assurance of confidentiality would facilitate support. | Agreement | Partial agreement | Partial agreement | Agreement |
Bold font indicates agreement across three or more arms.
Agreement: key finding has been identified; partial agreement: finding is partially covered; disagreement: contradictory statement; silence: not apparent; not addressed: subject not addressed in study.
*Disagreement only in the way that this was mentioned but dropped across the rounds, indicating that there was no consensus on this item, hence disagreement rather than silence.
CHI, Community Health Index.